Pemigatinib in cholangiocarcinoma with a FGFR2 rearrangement or fusion

Michael H. Storandt, Zhaohui Jin, Amit Mahipal

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Pemigatinib in cholangiocarcinoma with a FGFR2 rearrangement or fusion'. Together they form a unique fingerprint.

Medicine & Life Sciences